Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Reply to: The importance and challenge of pediatric trials of hemophilia drugs — Flora Peyvandi (2014) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Reply to: The importance and challenge of pediatric trials of hemophilia drugs
Shared by
Frits R. Rosendaal
Reply to: The importance and challenge of pediatric trials of hemophilia drugs
Letter
2014
English
Authors
+1 more
FP
Flora Peyvandi
Frits R. Rosendaal
Leiden University
BO
Brian O’Mahony
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2013
Mega-Randomized Clinical Trials for Blockbuster Drugs—Reply
John P A Ioannidis
Article
1999
Importance of Sleep in the Management of Pediatric Pain
D Lewin
,
Ronald E Dahl
Letter
2022
Author’s Reply to “MoNuSAC2020: A Multi-Organ Nuclei Segmentation and Classification Challenge”
Ruchika Verma
,
Neeraj Kumar
,
Abhijeet Patil
,
Nikhil Cherian Kurian
,
Swapnil Rane
,
Amit Sethi
Letter
2002
Reporting the clinical importance of randomized controlled trials.
David Moher
,
Douglas G. Altman
,
Kenneth F. Schulz
Article
2008
The challenge of clinical trials in the intensive care unit
Gustavo A. Ospina‐Tascón
,
Jean Louis Vincent
.jpg)
Discussion(0)
No comments yet. Be the first to comment.